Inhibition of SYK and cSrc kinases can protect bone and cartilage in preclinical models of osteoarthritis and rheumatoid arthritis
Abstract The pathophysiology of osteoarthritis (OA) includes the destruction of subchondral bone tissue and inflammation of the synovium. Thus, an effective disease-modifying treatment should act on both of these pathogenetic components. It is known that cSrc kinase is involved in bone and cartilage...
Guardado en:
Autores principales: | F. N. Novikov, M. V. Panova, I. Y. Titov, V. S. Stroylov, O. V. Stroganov, G. G. Chilov |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1740dcc49eee45d28bf18dcd98f4e729 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Estrogen Protects Articular Cartilage by Downregulating ASIC1a in Rheumatoid Arthritis
por: Hang X, et al.
Publicado: (2021) -
Preclinical Characterization of the Selective JAK1 Inhibitor LW402 for Treatment of Rheumatoid Arthritis
por: Zhang N, et al.
Publicado: (2021) -
RANKL expression in chondrocytes and its promotion by lymphotoxin-α in the course of cartilage destruction during rheumatoid arthritis.
por: Ayumu Takeshita, et al.
Publicado: (2021) -
Calcium calmodulin kinase II activity is required for cartilage homeostasis in osteoarthritis
por: Giovanna Nalesso, et al.
Publicado: (2021) -
Comparison of microRNA expression profiles of Kashin-Beck disease, osteoarthritis and rheumatoid arthritis
por: Wenhong Wu, et al.
Publicado: (2017)